Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 15/20 | 0.51 |
| ▸ | CNR1 | P21554 | 13/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.51 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13609358 | 0.80 | DRD3 (0.52) | CNR2CNR1DRD3 | |
| SCHEMBL10367356 | 0.71 | CNR2 (0.47) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL10365544 | 0.71 | CNR1 (0.57) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL31545670 | 0.71 | CNR2 (0.53) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL11268356 | 0.70 | CNR2 (0.87) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL19281379 | 0.70 | CNR1 (0.56) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL17843951 | 0.69 | CNR2 (0.52) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| SCHEMBL7258490 | 0.68 | CNR1 (0.62) | CNR2CNR1 | |
| Nabilone SCHEMBL15520922 | 0.67 | CNR2 (1.00) | CNR2CNR1NR1I2ADORA3SLC6A3 | |
| Nabilone SCHEMBL563809 | 0.67 | CNR2 (1.00) | CNR2CNR1NR1I2ADORA3SLC6A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090275649-A1 | Compositions And Methods For Identifying Modulars Of TRPV2 | QIN NING | 2009-11-05 | — | — | US | disclosed |
| US-20090275649-A1 | Compositions And Methods For Identifying Modulars Of TRPV2 | QIN NING | 2009-11-05 | — | — | US | disclosed |
| US-7575882-B2 | Compositions and methods for identifying modulators of TRPV2 | JANSSEN PHARMACEUTICA N. V. (BE) | 2009-08-18 | — | — | US | disclosed |
| US-7575882-B2 | Compositions and methods for identifying modulators of TRPV2 | JANSSEN PHARMACEUTICA N. V. (BE) | 2009-08-18 | — | — | US | disclosed |
| US-20070105086-A1 | Compositions and methods for identifying modulators of TRPV2 | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-05-10 | — | — | US | disclosed |
| US-20070105086-A1 | Compositions and methods for identifying modulators of TRPV2 | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-05-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090275649-A1 | Compositions And Methods For Identifying Modulars Of TRPV2 | TRPV2, TRPV1, TRPV3 | CNR2 8/4885CNR1 21/4885NR1I2 1772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.